|
Giving you the insight needed to assess, and access, the dynamics that facilitate success in the biotech market.
If you doubt the importance of this vital biotechnology drug market, consider that more than six out of every ten people you will personally encounter today are taking therapeutics for chronic disease or other acute conditions. The biggest senior citizen population in history is now forming and nothing is more poised to fight its pervasiveness than biotechnology.
The new BioWorld's Market-Leading Biotechnology Drugs 2009 concisely delivers precise acumen on the history, trends, value and projection of the ever-increasingly imperative biotech drug therapeutics market that has emerged to the forefront of government initiatives, business agendas and public concern and is impacting many aspects of industry, economics and life.
Viable business intelligence in this report includes:
- Which new technology is ordained to lead the fight against disease in the twenty-first century?
- Which drugmakers are projected to comprise the new list of large-cap biotechs in 2015?
- When will the combined drug market reach the trillion-dollar value mark?
- Which biotech drug has the potential to be the first-ever drug to generate $10 billion in annual revenue?
- What is the prevailing trend that will define the biotech drug market in the next decade?
- Which Big Biotech is undergoing FOB competition before its patents even expire, putting $4 billion in sales at risk?
- Who will be on the winning side of the biogenerics debate?
- What are the 41 drugs that accounted for $35 billion in 2008 revenue that will lose patent exclusivity through 2012?
- Which drugmakers are expected to comprise the new list of large-cap biotechs in 2015?
- And much more!
No matter what happens with health care reform, federal budgets, patent legislation, recession, or generics, the Holy Grail in biotech and pharma remains "The Drug." Its pursuit founded the industry, impels its growth and determines not only the future of the drug development market, but the health of the populace and the effective management of globally pervasive disease. Significant importance must be assigned to venture capital funds as biotech's Fountain of Youth, but ultimately, the drugs are the Alpha and Omega in this crucial equation and, arguably, the Most Important Industry on Earth!
Charts and tables include:
- Generics company rankings
- FDA drug approvals history
- Disease statistics
- Top pharma companies
- Clinical trial candidates
- Revenue
Drugs are winning the containment battle, but disease is winning the war and the dynamics are constantly changing. Keep up-to-date with BioWorld's Market-Leading Biotechnology Drugs 2009. This report is focused, nimble, efficient, meticulous, precise and value-packed.
Industry data includes comparative coverage of the top pharmaceutical drugs, leading generics companies, and extensive industry statistics for major aspects of the drug development market, including financings, patent expirations, revenue projections, product approvals, FDA submissions and drugs in development.
This report can be purchased in print or PDF.
To view the table of contents, click here.
|
Print and PDF Version:
|
|
Price: $199 + ($17.95 s&h)
|
Order Now
|
|
